Lonapegsomatropin-tcgd
Drug Details
- Generic Name
- Lonapegsomatropin-tcgd
- Brand Names
- Skytrofa
- Application Number
- BLA761177
- Sponsor
- Ascendis Pharma Endocrinology, Inc.
- NDC Codes
- 14
- Dosage Forms
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Routes
- SUBCUTANEOUS
- Active Ingredients
- LONAPEGSOMATROPIN
Indications and Usage
1 INDICATIONS AND USAGE SKYTROFA (lonapegsomatropin-tcgd) is a human growth hormone indicated for the: Treatment of pediatric patients 1 year and older who weigh at least 11.5 kg and have growth failure due to inadequate secretion of endogenous growth hormone (GH). Replacement of endogenous growth hormone in adults with growth hormone deficiency (GHD). SKYTROFA is a human growth hormone indicated for: Pediatric Patients: Treatment of pediatric patients 1 year and older who weigh at least 11.5 kg and have growth failure due to inadequate secretion of endogenous growth hormone (GH) ( 1 ). Adults: Replacement of endogenous growth hormone in adults with growth hormone deficiency (GHD) ( 1 ).